Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report
Ustekinumab is a fully human monoclonal antibody targeting the pro-inflammatory cytokines interleukin (IL)-12 and IL-23 approved for the treatment of psoriasis and psoriatic arthritis. We report a case of a patient treated for chronic plaque psoriasis with ustekinumab who developed bulky condyloma a...
Saved in:
Main Authors: | Martina Burlando (Author), Mattia Fabio Molle (Author), Emanuele Cozzani (Author), Aurora Parodi (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
by: Martina Burlando, MD, et al.
Published: (2020) -
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021) -
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021) -
A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice
by: Martina Burlando, et al.
Published: (2024) -
Childhood Condyloma Acuminata
by: Sengupta S.R, et al.
Published: (1999)